Westpac Banking Corp’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Westpac Banking Corp's NVO Position: Q3 2025 in Review
Westpac Banking Corp sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 43,895 shares — an estimated $3.03M sold.
Westpac Banking Corp first reported a position in NVO in Q3 2024 and held it in 4 quarters. The position peaked at $7.58M in Q3 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.
- Westpac Banking Corp reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
- Westpac Banking Corp sold 43,895 Novo Nordisk shares in Q3 2025, an estimated $3.03M.
- Westpac Banking Corp first reported a position in Novo Nordisk in Q3 2024 and held it in 4 quarters.
- Westpac Banking Corp's Novo Nordisk position peaked at $7.58M in Q3 2024.
- 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.
Based on Westpac Banking Corp's 13F filing for Q3 2025, filed 12 Nov 2025.